author-photo

Arie S. Belldegrun

University of California, Los Angeles

591

Papers

26201

Citations

Citation Trend

Filter By

Papers (436) Sort By

Journal Conference Others

A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.

2020 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (4)
Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients

2019 World Journal of Urology
Show All
- Source
- Cite
- Save
Citations (1)
Prognostic value of gain of chromosome 5q in localized renal cell carcinoma.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
The UCLA Histo-Genetic Risk Classification (U-HGRC) to predict outcomes of localized clear cell renal cell carcinoma.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase I, open-label, dose-escalation and cohort expansion study evaluating the safety and immune response to autologous dendritic cells transduced with AdGMCA9 in patients with metastatic renal cell carcinoma.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials

2018 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (32)
Utility of multiphasic multidetector computed tomography in discriminating between clear cell renal cell carcinomas with high and low carbonic anhydrase-IX expression

2018 Abdominal Radiology
Show All
- Source
- Cite
- Save
Citations (4)
Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma

2018 Urologic Oncology-seminars and Original Investigations
Show All
- Source
- Cite
- Save
Citations (4)
Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma

2018 Urologic Oncology-seminars and Original Investigations
Show All
- Source
- Cite
- Save
Citations (10)
A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer

2017 Urologic Oncology-seminars and Original Investigations
Show All
- Source
- Cite
- Save
Citations (23)